Drug intelligence / Profile preview

Biatain Fiber Ag

Development stage
Unknown
Lead developer
Coloplast
Administration
Topical
01

Overview

Biatain Fiber Ag is a **soft, sterile, primary wound dressing** composed primarily of non-woven **carboxymethylcellulose (CMC) gelling fibers** reinforced with bicomponent fibers and contains **0.63% ionic silver (Ag+)** for antimicrobial efficacy, as well as **ethyl lauroyl arginate (LAE)**, a surfactant and chelator[5][1]. Upon absorption of wound exudate, the dressing forms a conformable gel, releasing silver ions within the dressing to kill microorganisms (antimicrobial action), aid in autolytic debridement, and maintain a moist environment conducive to healing[5][1]. It is specifically intended for *moderate to highly exuding acute and chronic wounds*, functioning as a barrier to bacterial penetration and minimizing infection risk[5][1]. The product features **low shrinkage, high tensile strength, and high absorption**, enabling easy removal and reducing the risk of exudate pooling and maceration. The dressing is typically used with a secondary dressing and is designed for both clinical and at-home use[5][1]. Developed and manufactured by Coloplast, Biatain Fiber Ag is undergoing clinical evaluation for approval in several markets, including Europe[6][7][1].

Brand names
Biatain Fiber Ag

Beyond the preview

Go deeper on Biatain Fiber Ag.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biatain Fiber Ag.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call